clenbuterol has been researched along with Hypertension in 5 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
Excerpt | Relevance | Reference |
---|---|---|
"The present study was carried out to ascertain whether beta2-adrenergic receptor stimulation with clenbuterol would attenuate the pulmonary arterial, capillary and venous hypertension in horses performing high-intensity exercise and, in turn, modify the occurrence of exercise-induced pulmonary haemorrhage (EIPH)." | 9.09 | Clenbuterol administration does not attenuate the exercise-induced pulmonary arterial, capillary or venous hypertension in strenuously exercising Thoroughbred horses. ( Goetz, TE; Humphrey, S; Manohar, M; Rothenbaum, P, 2000) |
"The present study was carried out to ascertain whether beta2-adrenergic receptor stimulation with clenbuterol would attenuate the pulmonary arterial, capillary and venous hypertension in horses performing high-intensity exercise and, in turn, modify the occurrence of exercise-induced pulmonary haemorrhage (EIPH)." | 5.09 | Clenbuterol administration does not attenuate the exercise-induced pulmonary arterial, capillary or venous hypertension in strenuously exercising Thoroughbred horses. ( Goetz, TE; Humphrey, S; Manohar, M; Rothenbaum, P, 2000) |
"We analysed the influence of aging on the acute effect of clenbuterol, a beta(2)-adrenoceptor agonist, on the vasoconstrictor response induced by electrical field stimulation in mesenteric arteries from young and old spontaneously hypertensive rats (SHRs)." | 3.72 | Different effects of acute clenbuterol on vasomotor response in mesenteric arteries from young and old spontaneously hypertensive rats. ( Balfagón, G; Ferrer, M; Salaices, M; Sánchez, M, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ferrer, M | 1 |
Salaices, M | 1 |
Sánchez, M | 1 |
Balfagón, G | 1 |
Höcht, C | 1 |
Opezzo, JA | 1 |
Taira, CA | 1 |
Pöch, G | 1 |
Kim, J | 1 |
Shigetomi, S | 1 |
Tanaka, K | 1 |
Yamada, ZO | 1 |
Hashimoto, S | 1 |
Fukuchi, S | 1 |
Manohar, M | 1 |
Goetz, TE | 1 |
Rothenbaum, P | 1 |
Humphrey, S | 1 |
1 trial available for clenbuterol and Hypertension
Article | Year |
---|---|
Clenbuterol administration does not attenuate the exercise-induced pulmonary arterial, capillary or venous hypertension in strenuously exercising Thoroughbred horses.
Topics: Adrenergic beta-Agonists; Animals; Clenbuterol; Female; Hemorrhage; Horse Diseases; Horses; Hyperten | 2000 |
4 other studies available for clenbuterol and Hypertension
Article | Year |
---|---|
Different effects of acute clenbuterol on vasomotor response in mesenteric arteries from young and old spontaneously hypertensive rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Aging; Animals; Blood Pressure; Calcitonin G | 2003 |
Anterior hypothalamic beta-adrenergic activity in the maintenance of hypertension in aortic coarctated rats.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Anterior Hypothalamic Nucleus; Aorti | 2004 |
[Initial values and drug effects].
Topics: Asthma; Bezafibrate; Blood Pressure Determination; Chlorthalidone; Cholesterol; Clenbuterol; Humans; | 1984 |
[The role of beta 2-adrenoceptor on the pathogenesis of insulin resistance in essential hypertension].
Topics: Adrenergic beta-Agonists; Adult; Aged; Blood Glucose; Blood Pressure; Clenbuterol; Humans; Hypertens | 1994 |